Ionis Pharmaceuticals Inc... (IONS)

AI Score

Unlock

28.50

-0.21 (-0.73%)

At close: Apr 03, 2025, 3:59 PM

27.96

-1.86%

Pre-market: Apr 04, 2025, 06:51 AM EDT

Dividends

No dividend history available for Ionis Pharmaceuticals Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

IONS News

16 hours ago · Ionis to host expert panel discussion on sHTG - businesswire.com
3 days ago · Ionis to present at upcoming investor conferences - businesswire.com
1 week ago · IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi - zacks.com
1 week ago · Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. - businesswire.com
1 week ago · Why Is Ionis Pharmaceuticals (IONS) Up 0.1% Since Last Earnings Report? - zacks.com
3 weeks ago · Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera - businesswire.com
3 weeks ago · Ionis and Ono announce global license agreement for sapablursen in polycythemia vera - businesswire.com
3 weeks ago · WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy - businesswire.com
1 month ago · Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus - zacks.com
1 month ago · New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control - businesswire.com